Eureka projects

Reactive Oxygen Species (ROS) Activators to Treat the Rare disease Guillain-Barré Syndrome (GBS)

Selection and development of a therapeutic antibody against drug-resistant Klebsiella pneumoniae

Raising the productivity and competitiveness of European businesses through technology. Boosting national economies on the international market, and strengthening the basis for sustainable prosperity and employment.